Implantable Insulin Pump Market by Type (Closed-Loop Insulin Pump, and Open-Loop Insulin Pump), and by End User (Hospitals, and Individuals (Self-Medication)) - Global Opportunities and Forecasts, 2018-2025

Get 20% Free Customization In This Report

Medical Devices & Supplies	LI_183419	Pages: NA	May 2019 \| 1205 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Implantable insulin pump aids in delivering insulin into the peritoneal cavity and remains inside the body all the time. In addition, the insulin pump implanted in the peritoneal cavity helps in efficient absorption of insulin. The advent of implantable insulin pumps is anticipated to revolutionize the treatment of Type 1 diabetes and will also help find a constructive solution for truly effective artificial pancreas. Implantable insulin pumps are still considered to be new and can offer better treatment solutions for people who suffer from diabetes. The major factors that fuel the growth of the market are rise in the population that suffers from diabetes along with increasing awareness about insulin treatment that is available in the market. In addition, technological advancements in implantable insulin pumps supplement the market growth. However, stringent regulations regarding the approval of implantable insulin pumps along with limited availability of these pumps restrain the growth of the implantable insulin pumps market.

The report segments the market on the basis of type, end user, and region. Based on type, the market is divided into closed-loop insulin pump and open-loop insulin pump. Based on end user, the market is classified into hospitals and individuals (self-medication). Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this market are Medtronic, Insulet Corporation, F. Hoffmann La Roche Ltd., Animas corporation, SOOIL Developments Co., Ltd., Johnson & Johnson, Tandem Diabetes Care, Inc., and Aetna Inc.

Key Benefits

The study provides an in-depth analysis of the global implantable insulin pumps market, with current trends and future estimations to elucidate imminent investment pockets.
It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the market by type assists in understanding various forms of implantable insulin pumps that are available.
Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

Implantable Insulin Pump Market Key Segmentation:

By Type

Closed-Loop Insulin Pump
Open-Loop Insulin Pump

By End User

Hospitals
Individuals (Self-Medication)

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Argentina
- Rest of LAMEA

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities

Chapter: 4 GLOBAL IMPLANTABLE INSULIN PUMP MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CLOSED-LOOP INSULIN PUMP

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. OPEN-LOOP INSULIN PUMP

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 GLOBAL IMPLANTABLE INSULIN PUMP MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. INDIVIDUALS (SELF-MEDICATION)

5.3.1. Market size and forecast

Chapter: 6 GLOBAL IMPLANTABLE INSULIN PUMP MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Implantable Insulin Pump Market by Type
6.2.5. North America Implantable Insulin Pump Market Market by End user

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Implantable Insulin Pump Market by Type
6.3.5. Europe Implantable Insulin Pump Market by End user

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Implantable Insulin Pump Market by Type
6.4.5. Asia-Pacific Implantable Insulin Pump Market by End user

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. Argentina market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Implantable Insulin Pump Market by Type
6.5.5. LAMEA Implantable Insulin Pump Market by End user

Chapter: 7 COMPANY PROFILES

7.1. MEDTRONIC

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. INSULET CORPORATION

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. F. HOFFMANN LA ROCHE LTD.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. ANIMAS CORPORATION

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. SOOIL DEVELOPMENTS CO., LTD.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. JOHNSON & JOHNSON

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. TANDEM DIABETES CARE, INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. AETNA INC.

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Implantable Insulin Pump Market by Type (Closed-Loop Insulin Pump, and Open-Loop Insulin Pump), and by End User (Hospitals, and Individuals (Self-Medication)) - Global Opportunities and Forecasts, 2018-2025